title: Vasculitis, vitiligo, thyroiditis, and altered hormone levels after anti-tumor necrosis factor therapy.
authors.forename: Robert G
authors.initials: RG
authors.lastname: Lahita
authors.forename: Melchiore A
authors.initials: MA
authors.lastname: Vernace
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D015535:Arthritis, Psoriatic / Q000188:drug therapy; D004958:Estradiol / Q000097:blood; D006801:Humans; D000069285:Infliximab; D008297:Male; D008875:Middle Aged; D013966:Thyroiditis / Q000139:chemically induced*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*; D014657:Vasculitis / Q000139:chemically induced*; D014820:Vitiligo / Q000139:chemically induced*
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D004958:Estradiol; D000069285:Infliximab